Cliramitug
Cliramitug is a monoclonal antibody targeting human transthyretin (TTR) . Cliramitug binds to TTR to inhibit its amyloid-forming process, exerting activity against amyloid protein formation. Cliramitug is promising for research of diseases related to transthyretin amyloidosis, such as certain neurological and cardiovascular diseases[1].
Product Specifications
CAS Number
[2965214-50-8]
Product Name Alternative
NI-006; ALXN2220
UNSPSC
12352203
Target
Transthyretin (TTR)
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Purity
97.0
Smiles
[Cliramitug]
Molecular Weight
(144.542 kDa)
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15154962 1 Vial
Lentiviral human ACTRT1 shRNA (UAS) - Lentiviral human ACTRT1 shRNA (UAS) (100)
Ask
View Details 
GTR15353022 1 Vial
Lentiviral human GPBP1L1 shRNA (UAS) - Lentiviral human GPBP1L1 shRNA (UAS, iRFP) (100)
Ask
View Details GTR15329288 1 Vial
Lentiviral human KLHDC2 shRNA (UAS) - Lentiviral human KLHDC2 shRNA (UAS) (25)
Ask
View Details